Sanofi

Clinical Study Results Medicines, including Rare Diseases

Important

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country. In the event that the product is described as no longer a Sanofi product, reasons could include that the product was transferred to another company.

This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

Filter by:

And

1248 result(s) found
Generic NameTrade NameCondition(s)Study CodeStudy NameAccess to Study / ProtocolAccess to Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
LPS14585NAEudraCT: 2015-004843-38Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
LPS14587NANCT02688933Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
LPS15396ARTEMIS-DMNCT03760991Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
LPS16665SAFEGUARDNCT04980027Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
MSC15146eStudyNCT03260868Tabulated Results
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
OBS14708ATOSNCT03703869Publication reference
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
PDY12335NANCT01676233Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
PDY12777NANCT01658579Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 2
PDY14065NANCT02227212Summary
INSULIN GLARGINE NEW FORMULATION
Toujeo
Diabetes Mellitus, Type 1
PKD13560NANCT01838083Summary

References:

* These study results were previously posted on GenzymeClinicalResearch.com
** This link replaces the same summary that was previously posted